A RING Finger Ubiquitin Ligase Is Protected from Autocatalyzed Ubiquitination and Degradation by Binding to Ubiquitin-specific Protease USP7*

Herpes simplex virus type 1 immediate-early regulatory protein ICP0 stimulates lytic infection and reactivation from latency, processes that require the ubiquitin E3 ligase activity mediated by the RING finger domain in the N-terminal portion of the protein. ICP0 stimulates the production of polyubiquitin chains by the ubiquitin-conjugating enzymes UbcH5a and UbcH6 in vitro, and in infected and transfected cells it induces the proteasome-dependent degradation of a number of cellular proteins including PML, the major constituent protein of PML nuclear bodies. However, ICP0 binds strongly to the cellular ubiquitin-specific protease USP7, a member of a family of proteins that cleave polyubiquitin chains and/or ubiquitin precursors. The region of ICP0 that is required for its interaction with USP7 has been mapped, and mutations in this domain reduce the functionality of ICP0. These findings pose the question: why does ICP0 include domains that are associated with the potentially antagonistic functions of ubiquitin conjugation and deconjugation? Here we report that although neither protein affected the intrinsic activities of the other in vitro, USP7 protected ICP0 from autoubiquitination in vitro, and their interaction can greatly increase the stability of ICP0 in vivo. These results demonstrate that RING finger-mediated autoubiquitination of ICP0 is biologically relevant and can be regulated by interaction with USP7. This principle may extend to a number of cellular RING finger E3 ubiquitin ligase proteins that have analogous interactions with ubiquitin-specific cleavage enzymes.

[1]  C. Boutell,et al.  Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner , 2004, Journal of Virology.

[2]  B. Vogelstein,et al.  HAUSP is Required for p53 Destabilization , 2004, Cell cycle.

[3]  Muyang Li,et al.  A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.

[4]  B. Roizman,et al.  Role of ICP0 in the Strategy of Conquest of the Host Cell by Herpes Simplex Virus 1 , 2004, Journal of Virology.

[5]  C. Boutell,et al.  Phenotype of a Herpes Simplex Virus Type 1 Mutant That Fails To Express Immediate-Early Regulatory Protein ICP0 , 2004, Journal of Virology.

[6]  B. Roizman,et al.  HerpesSimplex Virus 1 Mutant in Which the ICP0 HUL-1 E3 Ubiquitin Ligase SiteIs Disrupted Stabilizes cdc34 but Degrades D-Type Cyclins andExhibits DiminishedNeurotoxicity , 2003, Journal of Virology.

[7]  M. Gellert,et al.  Autoubiquitylation of the V(D)J recombinase protein RAG1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Boutell,et al.  The Herpes Simplex Virus Type 1 (HSV-1) Regulatory Protein ICP0 Interacts with and Ubiquitinates p53* , 2003, Journal of Biological Chemistry.

[9]  K. Burns,et al.  Ubiquitination of the Epstein–Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site , 2003, Oncogene.

[10]  C. Boutell,et al.  PML Residue Lysine 160 Is Required for the Degradation of PML Induced by Herpes Simplex Virus Type 1 Regulatory Protein ICP0 , 2003, Journal of Virology.

[11]  René Bernards,et al.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.

[12]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[13]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[14]  J. Greenblatt,et al.  Protein Profiling with Epstein-Barr Nuclear Antigen-1 Reveals an Interaction with the Herpesvirus-associated Ubiquitin-specific Protease HAUSP/USP7* , 2003, Journal of Biological Chemistry.

[15]  C. Dargemont,et al.  Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23 , 2003, Nature Cell Biology.

[16]  S. Fang,et al.  RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. , 2003, Seminars in cancer biology.

[17]  Muyang Li,et al.  Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde , 2002, Cell.

[18]  T. Ouchi,et al.  Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase* , 2002, The Journal of Biological Chemistry.

[19]  I. Choi,et al.  USP7, a Ubiquitin-Specific Protease, Interacts with Ataxin-1, the SCA1 Gene Product , 2002, Molecular and Cellular Neuroscience.

[20]  K. Brown,et al.  Regulation of TRAF2 Signaling by Self-induced Degradation* , 2002, The Journal of Biological Chemistry.

[21]  J. Qin,et al.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.

[22]  C. Van Sant,et al.  Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Boutell,et al.  Herpes Simplex Virus Type 1 Immediate-Early Protein ICP0 and Its Isolated RING Finger Domain Act as Ubiquitin E3 Ligases In Vitro , 2002, Journal of Virology.

[24]  M. Ferrone,et al.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[26]  A. Godzik,et al.  A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-associated Factor Domains* , 2001, The Journal of Biological Chemistry.

[27]  H. Yasuda,et al.  N-Terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8. , 2001, European journal of biochemistry.

[28]  Kentaro Kato,et al.  Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Everett,et al.  Alphaherpesvirus Proteins Related to Herpes Simplex Virus Type 1 ICP0 Affect Cellular Structures and Proteins , 2000, Journal of Virology.

[30]  R. Everett ICP0 Induces the Accumulation of Colocalizing Conjugated Ubiquitin , 2000, Journal of Virology.

[31]  A. Weissman,et al.  RING Finger Proteins Mediators of Ubiquitin Ligase Activity , 2000, Cell.

[32]  R. Everett ICP0, a regulator of herpes simplex virus during lytic and latent infection. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[33]  Yili Yang,et al.  Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. , 2000, Science.

[34]  Shengyun Fang,et al.  Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.

[35]  S. H. Baek,et al.  Deubiquitinating enzymes: their diversity and emerging roles. , 1999, Biochemical and biophysical research communications.

[36]  A. Dejean,et al.  Viral Immediate-Early Proteins Abrogate the Modification by SUMO-1 of PML and Sp100 Proteins, Correlating with Nuclear Body Disruption , 1999, Journal of Virology.

[37]  W. Earnshaw,et al.  Specific destruction of kinetochore protein CENP‐C and disruption of cell division by herpes simplex virus immediate‐early protein Vmw110 , 1999, The EMBO journal.

[38]  Mounira K Chelbi-Alix,et al.  Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins , 1999, Oncogene.

[39]  R. Everett,et al.  The Ability of Herpes Simplex Virus Type 1 Immediate-Early Protein Vmw110 To Bind to a Ubiquitin-Specific Protease Contributes to Its Roles in the Activation of Gene Expression and Stimulation of Virus Replication , 1999, Journal of Virology.

[40]  R. Everett,et al.  A viral activator of gene expression functions via the ubiquitin–proteasome pathway , 1998, The EMBO journal.

[41]  P. Freemont,et al.  The Disruption of ND10 during Herpes Simplex Virus Infection Correlates with the Vmw110- and Proteasome-Dependent Loss of Several PML Isoforms , 1998, Journal of Virology.

[42]  N. DeLuca,et al.  Persistence and Expression of the Herpes Simplex Virus Genome in the Absence of Immediate-Early Proteins , 1998, Journal of Virology.

[43]  Keith D Wilkinson,et al.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression , 1998, Oncogene.

[44]  C. Van Sant,et al.  Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3 , 1997, Journal of virology.

[45]  R. Everett,et al.  A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.

[46]  B. Roizman,et al.  Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery , 1997, Journal of virology.

[47]  P. Schaffer,et al.  An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1 , 1995, Journal of virology.

[48]  P. Schaffer,et al.  Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4 , 1994, Journal of virology.

[49]  R. Everett,et al.  A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. , 1993, Virology.

[50]  R. Everett,et al.  An epitope within the DNA-binding domain of the herpes simplex virus immediate early protein Vmw175 is conserved in the varicella-zoster virus gene 62 protein. , 1993, The Journal of general virology.

[51]  R. Everett Construction and characterization of herpes simplex type 1 viruses without introns in immediate early gene 1. , 1991, The Journal of general virology.

[52]  R. Everett Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. , 1989, The Journal of general virology.

[53]  R. Everett A detailed mutational analysis of Vmw110, a trans‐acting transcriptional activator encoded by herpes simplex virus type 1. , 1987, The EMBO journal.

[54]  S. Showalter,et al.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4 , 1981, Infection and immunity.

[55]  Yuan-Tsong Chen,et al.  A marker for Stevens–Johnson syndrome , 2004 .

[56]  C. Preston Repression of viral transcription during herpes simplex virus latency. , 2000, The Journal of general virology.